IRVINE, Calif., Nov. 12, 2018 /PRNewswire-PRWeb/ -- Biomin® the innovative new toothpaste which slowly releases calcium and phosphorus ions, thus effectively replacing lost mineral from tooth surfaces, is now available in the United States through Dr Collins Inc, California. This is directly available at https://drcollins.com/dr-collins-biomin-toothpaste.html as well as through amazon.com at https://www.amazon.com/dp/B07H944RLG
BioMin toothpaste contains a patented bioactive glass material developed by a research team led by Professor Robert Hill at Queen Mary University of London. The product was launched in the United Kingdom in April 2016 and is currently available in Europe, the Middle East and Asia.
"BioMin toothpaste contains elements found naturally in the body including calcium, phosphorus, sodium and silica," said Professor Robert Hill, co-founder of BioMin and Chair of Dental Physical Sciences at Queen Mary University of London. "BioMin works when water and saliva in the mouth break down the bioactive glass within the toothpaste and slowly releases the calcium and phosphate ions to deliver hydroxyapatite onto the surface of the tooth. These ions then rapidly form an effective seal over open dentine tubules."
"This means that BioMin is more effective at replacing lost mineral from tooth surfaces than conventional toothpastes," said Professor Hill.
Oral care is critically important as dental decay is a prevalent disease worldwide. According to the latest US National Health and Nutrition Examination Survey, approximately 91% of US adults aged 20–64 have dental cavities in permanent teeth with more than a quarter having untreated tooth decay.
Tooth decay is widespread among children: In younger children (ages 2 to 11), 42% have dental cavities in their primary teeth; with nearly one quarter going untreated. In the 12-19 age group, 59% have dental cavities in their permanent teeth; with one in five having untreated decay.
Since its launch in 2008, the Dr. Collins® brand has been at the leading edge of oral care technology. Its innovative products – toothpastes, Perio Toothbrush® and Perio Pic® – are distributed through a variety of channels, including retail stores, online outlets and professional dental offices.
According to the company's founder and dentist, Dr. Colin Suzman, "Imagine not eating ice cream or drinking a hot chocolate because you're afraid how it will make your sensitive teeth feel? BioMin toothpaste contains a patented ceramic glass that can bring back the enjoyment of these and other hot and cold foods and drinks. Plus it is fluoride free for those individuals who don't want fluoride. US Consumers have been unable to avail themselves of this Technology in Toothpastes following GlaxoSmithKline's acquisition of Novamin, so I am excited to finally bring this technology back to the United States."
"We are delighted we are now selling BioMin toothpaste in the United States," said Richard Whatley, chief executive officer of BioMin Technologies. "Our new 'bioglass' toothpaste has been very well received by consumers as well as by many dentists and hygienists across the world who fully respect the science which supports its development and its provenance."
BioMin toothpaste is now available on the Dr.Collins website at https://drcollins.com/dr-collins-biomin-toothpaste.html as well as through amazon.com at https://www.amazon.com/dp/B07H944RLG For further information, please visit http://www.drcollins.com or http://www.biomin.co.uk
Notes to Editors
Professor Robert Hill
Co-Founder and Director of Research at BioMin Technologies Ltd and currently the Chair of Physical Sciences in the Dental Institute at Queen Mary University of London. Professor Hill was formerly Professor of Biomaterials at Imperial College and is an expert on bioactive glass and apatite chemistry. He developed a cement (Serenocem) for sticking Cochlear implants in place and repairing the ossicular chain. This cement, which is produced by Corinthian, has gained FDA approval and is distributed worldwide.
Professor Hill was part of the Materials Group at LGC that won the Queens Award for Technological Achievement in 1984 and in 2013 he received the Alan Wilson Award for Dental Materials.
BioMin
BioMin Technologies Ltd was established in 2014 to commercialise research conducted over the past decade at Queen Mary University London and Imperial College, London, to develop bioactive glass materials to reduce tooth sensitivity, help replace lost mineral from tooth surfaces and protect against tooth decay. The company received the 2013 Worshipful Company Armourers and Brasiers' Venture Prize for innovation. BioMin's technology is based on two key patent applications: the first is on fluoride containing bioactive glasses and the second is on chloride containing bioactive glasses. BioMin based toothpaste is currently available in the UK and across other European countries including Germany as well as in India and Australia and New Zealand.
SOURCE BIOMIN
Advertisement
BioMin toothpaste contains a patented bioactive glass material developed by a research team led by Professor Robert Hill at Queen Mary University of London. The product was launched in the United Kingdom in April 2016 and is currently available in Europe, the Middle East and Asia.
Advertisement
"BioMin toothpaste contains elements found naturally in the body including calcium, phosphorus, sodium and silica," said Professor Robert Hill, co-founder of BioMin and Chair of Dental Physical Sciences at Queen Mary University of London. "BioMin works when water and saliva in the mouth break down the bioactive glass within the toothpaste and slowly releases the calcium and phosphate ions to deliver hydroxyapatite onto the surface of the tooth. These ions then rapidly form an effective seal over open dentine tubules."
"This means that BioMin is more effective at replacing lost mineral from tooth surfaces than conventional toothpastes," said Professor Hill.
Oral care is critically important as dental decay is a prevalent disease worldwide. According to the latest US National Health and Nutrition Examination Survey, approximately 91% of US adults aged 20–64 have dental cavities in permanent teeth with more than a quarter having untreated tooth decay.
Tooth decay is widespread among children: In younger children (ages 2 to 11), 42% have dental cavities in their primary teeth; with nearly one quarter going untreated. In the 12-19 age group, 59% have dental cavities in their permanent teeth; with one in five having untreated decay.
Since its launch in 2008, the Dr. Collins® brand has been at the leading edge of oral care technology. Its innovative products – toothpastes, Perio Toothbrush® and Perio Pic® – are distributed through a variety of channels, including retail stores, online outlets and professional dental offices.
According to the company's founder and dentist, Dr. Colin Suzman, "Imagine not eating ice cream or drinking a hot chocolate because you're afraid how it will make your sensitive teeth feel? BioMin toothpaste contains a patented ceramic glass that can bring back the enjoyment of these and other hot and cold foods and drinks. Plus it is fluoride free for those individuals who don't want fluoride. US Consumers have been unable to avail themselves of this Technology in Toothpastes following GlaxoSmithKline's acquisition of Novamin, so I am excited to finally bring this technology back to the United States."
"We are delighted we are now selling BioMin toothpaste in the United States," said Richard Whatley, chief executive officer of BioMin Technologies. "Our new 'bioglass' toothpaste has been very well received by consumers as well as by many dentists and hygienists across the world who fully respect the science which supports its development and its provenance."
BioMin toothpaste is now available on the Dr.Collins website at https://drcollins.com/dr-collins-biomin-toothpaste.html as well as through amazon.com at https://www.amazon.com/dp/B07H944RLG For further information, please visit http://www.drcollins.com or http://www.biomin.co.uk
Notes to Editors
Professor Robert Hill
Co-Founder and Director of Research at BioMin Technologies Ltd and currently the Chair of Physical Sciences in the Dental Institute at Queen Mary University of London. Professor Hill was formerly Professor of Biomaterials at Imperial College and is an expert on bioactive glass and apatite chemistry. He developed a cement (Serenocem) for sticking Cochlear implants in place and repairing the ossicular chain. This cement, which is produced by Corinthian, has gained FDA approval and is distributed worldwide.
Professor Hill was part of the Materials Group at LGC that won the Queens Award for Technological Achievement in 1984 and in 2013 he received the Alan Wilson Award for Dental Materials.
BioMin
BioMin Technologies Ltd was established in 2014 to commercialise research conducted over the past decade at Queen Mary University London and Imperial College, London, to develop bioactive glass materials to reduce tooth sensitivity, help replace lost mineral from tooth surfaces and protect against tooth decay. The company received the 2013 Worshipful Company Armourers and Brasiers' Venture Prize for innovation. BioMin's technology is based on two key patent applications: the first is on fluoride containing bioactive glasses and the second is on chloride containing bioactive glasses. BioMin based toothpaste is currently available in the UK and across other European countries including Germany as well as in India and Australia and New Zealand.
SOURCE BIOMIN
